Bioscience Pharma Competitors and Similar CompaniesClear all

Bioscience Pharma's competitors and similar companies include Chugai Pharmaceutical, Symphogen, Immunomedics and Acepodia.

	Bioscience Pharma Bioscience Pharma is a company focusing on neuroinflammation and neurodegenerative diseases.	Chugai Pharmaceutical Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases.	Symphogen Symphogen is a biotech company focused on oncology and immuno-oncology.	Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.	Acepodia Acepodia is a biotech company developing cell therapies for cancer.
Founding Date	Founding Date 2013	Founding Date 1925	Founding Date 2000	Founding Date 1982	Founding Date 2016
Type	Type Private	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations HQ	Locations Chuo City, JP HQ Guangzhou Shi, CN Taizhou, CN Puteaux, FR Frankfurt Am Main, DE Singapore, SG see more	Locations Ballerup, DK HQ Somerville, US	Locations Morris Plains, US HQ	Locations TW HQ San Mateo, US
Employees	Employees 6	Employees 7,778	Employees 196	Employees 8914% decrease	Employees 514% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥1.3t (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $295k (FY, 2019)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ¥363.7b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥903.5b (FY, 2025)	Gross profit N/A	Gross profit $295k (FY, 2019)	Gross profit N/A
Net income	Net income N/A	Net income ¥434b (FY, 2025)	Net income N/A	Net income ($357.3m) (FY, 2019)	Net income N/A
Funding
Total funding raised	Total funding raised $ 2.5m	Total funding raised N/A	Total funding raised $ 387.2m	Total funding raised $ 30m	Total funding raised N/A